Home Market News Small Caps Anticipation Rises as Hibbett Braces for Earnings Call; Analysts Adjust Forecasts with Precision

Anticipation Rises as Hibbett Braces for Earnings Call; Analysts Adjust Forecasts with Precision

0
Anticipation Rises as Hibbett Braces for Earnings Call; Analysts Adjust Forecasts with Precision

Hibbett, Inc. HIBB is gearing up to unveil its financial performance for the fourth quarter, with the announcement scheduled before the opening bell on March 15, 2024.

Projections indicate that the Birmingham-based Hibbett may disclose quarterly earnings of $2.56 per share, a slight decrease from the $2.91 per share reported in the corresponding period last year. Anticipated revenue for the latest quarter stands at $477.49 million, showing growth from the $458.3 million logged in the prior-year quarter, information sourced from Benzinga Pro reveals.

In a triumph of sorts, Hibbett surprised the markets on Nov. 21 by outperforming expectations with a third-quarter sales figure of $431.92 million, surpassing the analyst consensus of $416.02 million. Despite this victory, Hibbett experienced a 1.8% dip in its share price, closing at $73.03 on Thursday.

Enthusiasts following Benzinga’s intel can stay up-to-date with the latest analyst assessments on the Analyst Stock Ratings page. They have the option to filter by stock ticker, company name, analyst group, rating fluctuations, and other parameters.

Curious about how Hibbett has fared in the eyes of Benzinga’s most astute analysts recently? Here are their evaluations of the company:

  • Telsey Advisory Group analyst Joseph Feldman, maintaining an Outperform stance, revised the price target from $73 to $82 on March 13, 2024. This analyst boasts a formidable 74% accuracy rate.
  • Baird analyst Peter Benedict, sticking with an Outperform rating, increased the price target from $50 to $56 on Aug. 28, 2023. Notably, this analyst has proven his mettle with a commendable 70% accuracy rate.
  • Benchmark analyst John Lawrence reaffirmed a Buy rating alongside a $80 price target on Aug. 28, 2023. This pundit commands a respectable accuracy rate of 68%.
  • Williams Trading analyst Sam Poser upgraded the stock from Hold to Buy on Aug. 25, 2023. This discerning analyst exhibits an impressive accuracy rate of 71%.

 

Explore Further: Simple Strategies To Earn $500 Monthly Investing in Pfizer Stock Post an Unexpectedly Upbeat Quarter